Windtree Therapeutics Inc
WINT
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.37K
Close$
$-0.82
74445.5% downside
Current Fair Value
74445.5% downsideOvervalued by 74445.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3,371.00 |
|---|---|
| Enterprise Value | $3.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-104.35 |
| Beta | 1.62 |
| Outstanding Shares | 26,675 |
Return
| Return on Equity | -506155.56% |
|---|---|
| Return on Assets | -285.02% |
| Return on Invested Capital | 128.91% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 70.52 |
| Enterprise Value to EBIT | -0.42 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | 374.89 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Windtree Therapeutics Inc
31 employeesWindtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset franc...